| 发明名称 | Treatment of NAFLD and NASH | ||
| 摘要 | Treatment of NAFLD and NASH by therapy with MBX-8025 or an MBX-8025 salt. | ||
| 申请公布号 | US9616039(B2) | 申请公布日期 | 2017.04.11 |
| 申请号 | US201615171910 | 申请日期 | 2016.06.02 |
| 申请人 | CYMABAY THERAPEUTICS, INC. | 发明人 | Roberts Brian;Wang Xueyan;Choi Yun-Jung;Karpf David;Martin Robert;McWherter Charles |
| 分类号 | A61K31/192;A61K31/33;A61K9/00 | 主分类号 | A61K31/192 |
| 代理机构 | Hamilton Desanctis & Cha, LLP | 代理人 | Nguyen Sam L.;Hamilton Desanctis & Cha, LLP |
| 主权项 | 1. A method of treating a disease that is non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH) by orally administering a therapeutically effective amount of (R)-2-(4-((2-ethoxy-3-(4-(trifluoromethyl)phenoxy)propyl)thio)-2-methylphenoxy)-acetic acid (MBX-8025) or a salt thereof. | ||
| 地址 | Newark CA US | ||